The following table details the insider trading activities
(stock purchases, stock sales, and stock option exercises) by Wiezorek Jeffrey since 2015.
The trader's CIK number is 1610823.
At the time of the last reporting, Wiezorek Jeffrey was the VP Clinical Development of Kite Pharma, Inc.. (stock ticker symbol KITE).
Also see all insider trading activities at Kite Pharma, Inc..
| Insider Buying | Insider Sales | Option Exercises | |||||
|---|---|---|---|---|---|---|---|
| Year | Symbol | Shares | Value | Shares | Value | Shares | Value |
| 2017 | KITE | 0 | $0 | 36,283 | $3,494,103 | 31,000 | $213,590 |
| 2016 | KITE | 0 | $0 | 40,500 | $2,022,403 | 40,500 | $279,045 |
| 2015 | KITE | 4,000 | $68,000 | 72,000 | $4,589,289 | 72,000 | $496,080 |
| Trade Date | Symbol | Trade Type | Shares | Price ($) | Value ($) |
|---|---|---|---|---|---|
| 2017-09-25 | KITE | Sale | 5,283 | 179.66 | 949,164 |
| 2017-07-03 | KITE | Option Ex | 10,000 | 6.89 | 68,900 |
| 2017-07-03 | KITE | Sale | 10,000 | 104.51 | 1,045,100 |
| 2017-03-01 | KITE | Option Ex | 18,000 | 6.89 | 124,020 |
| 2017-03-01 | KITE | Sale | 18,000 | 74.89 | 1,348,020 |
| 2017-02-01 | KITE | Sale | 1,500 | 51.21 | 76,819 |
| 2017-02-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2017-01-06 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2017-01-06 | KITE | Sale | 1,500 | 50.00 | 75,000 |
| 2016-12-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-12-01 | KITE | Sale | 1,500 | 50.95 | 76,432 |
| 2016-12-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-12-01 | KITE | Sale | 1,500 | 50.95 | 76,432 |
| 2016-11-10 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-11-10 | KITE | Sale | 1,500 | 50.18 | 75,270 |
| 2016-10-03 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-10-03 | KITE | Sale | 1,500 | 55.12 | 82,672 |
| 2016-09-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-09-01 | KITE | Sale | 1,500 | 58.38 | 87,562 |
| 2016-08-01 | KITE | Sale | 1,500 | 56.95 | 85,425 |
| 2016-08-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-07-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-07-01 | KITE | Sale | 1,500 | 50.01 | 75,007 |
| 2016-06-01 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-05-31 | KITE | Option Ex | 1,500 | 6.89 | 10,335 |
| 2016-06-01 | KITE | Sale | 1,500 | 51.56 | 77,340 |
| 2016-05-31 | KITE | Sale | 1,500 | 50.00 | 75,000 |
| 2016-03-15 | KITE | Sale | 9,000 | 46.05 | 414,432 |
| 2016-03-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2016-02-16 | KITE | Sale | 9,000 | 44.23 | 398,115 |
| 2016-02-16 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2016-01-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2016-01-15 | KITE | Sale | 9,000 | 55.41 | 498,716 |
| 2015-12-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-12-15 | KITE | Sale | 9,000 | 64.02 | 576,180 |
| 2015-11-16 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-11-16 | KITE | Sale | 9,000 | 78.42 | 705,744 |
| 2015-10-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-10-15 | KITE | Sale | 9,000 | 62.45 | 562,068 |
| 2015-09-15 | KITE | Sale | 9,000 | 64.34 | 579,060 |
| 2015-09-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-08-17 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-08-17 | KITE | Sale | 9,000 | 61.08 | 549,747 |
| 2015-07-15 | KITE | Sale | 9,000 | 71.73 | 645,588 |
| 2015-07-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2014-06-25 | KITE | Buy | 4,000 | 17.00 | 68,000 |
| 2015-06-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-06-15 | KITE | Sale | 9,000 | 56.95 | 512,550 |
| 2015-05-15 | KITE | Option Ex | 9,000 | 6.89 | 62,010 |
| 2015-05-15 | KITE | Sale | 9,000 | 50.93 | 458,352 |
Insider trading activities including stock purchases, stock sales, and option exercises listed in the above table cannot be completely guaranteed as to their accuracy. For more information regarding the trades made by Wiezorek Jeffrey (VP Clinical Development of Kite Pharma, Inc. at the time of this reporting) see the Securities and Exchange Commission (SEC) website.